The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 08, 2017

Filed:

Oct. 30, 2013
Applicant:

Takeda Pharmaceutical Company Limited, Osaka-shi, Osaka, JP;

Inventors:

Shumpei Murata, Fujisawa, JP;

Shinichi Masada, Fujisawa, JP;

Naoki Miyamoto, Fujisawa, JP;

Tadashi Umemoto, Fujisawa, JP;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07F 9/6561 (2006.01); C07H 21/02 (2006.01); C07F 9/6558 (2006.01); C07H 21/00 (2006.01); C07D 239/54 (2006.01); C07D 473/34 (2006.01); C07F 9/6512 (2006.01);
U.S. Cl.
CPC ...
C07F 9/65616 (2013.01); C07D 239/54 (2013.01); C07D 473/34 (2013.01); C07F 9/65121 (2013.01); C07F 9/65583 (2013.01); C07F 9/65586 (2013.01); C07H 21/00 (2013.01); C07H 21/02 (2013.01);
Abstract

Provided is an oligonucleic acid analog which contains, as at least one structural unit thereof, a modified nucleic acid monomer compound which is a ring-open nucleoside having a cleaved carbon-carbon bond between the 2' and 3′ positions and a substituent hydroxymethyl group at the 4′ position. When used as siRNA, the oligonucleic acid analog exhibits superior biological stability and target gene expression inhibiting activity. The oligonucleic acid analog can be used in antisense methods, ribozyme methods, and decoy methods, etc., can be used as a nucleic acid aptamer, and can also be used as a nucleic acid probe or molecular beacon, etc., or in genetic diagnostics, etc.


Find Patent Forward Citations

Loading…